• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 88 of 100
Pfizer And AstraZeneca's Billion Dollar Battle
Leadership
A Pfizer Deal With Allergan Would Add Fuel to the Fight Over Taxes
By Alan MurrayNovember 19, 2015
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
Leadership
The Treasury Will Crack Down on ‘Tax Inversions’ This Week
By Geoffrey SmithNovember 19, 2015
571977919
Health
Global Drug Spending Will Reach $1.4 Trillion by 2020
By Laura LorenzettiNovember 18, 2015
Police Operation in Saint Denis
Tech
Paris Siege and Square Prices IPO–5 Things to Know Today
By Laura Lorenzetti and Geoffrey SmithNovember 18, 2015
Flibanserin
Health
Why ‘Female Viagra’ Is Not Selling
By Robert HackettNovember 17, 2015
14th Annual Elton John AIDS Foundation An Enduring Vision Benefit - Show
Finance
Why Mylan Just Lost The Largest Hostile Takeover Battle Ever
By Jen WiecznerNovember 13, 2015
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
Leadership
Mylan, Valeant and Theranos: What the Heck, Biotech?
By Jeffrey SonnenfeldNovember 13, 2015
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
Health
Mylan’s Hostile Bid for Perrigo Fails
By ReutersNovember 13, 2015
Bill Ackman
Health
Valeant, Ackman Must Face U.S. Insider Trading Lawsuit
By ReutersNovember 11, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance
Valeant CEO Defends Firm but Says He Doesn’t Have ‘Full Knowledge’
By Stephen GandelNovember 10, 2015
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
Health
Astrazeneca is Buying ZS Pharma for $2.7 billion
By Laura LorenzettiNovember 6, 2015
Walgreens-Rite Aid deal could lead to elimination of 3,000 stores
Retail
Walgreens-Rite Aid deal could lead to elimination of 3,000 stores
By Phil WahbaNovember 5, 2015
MSMB Capital Management CIO Martin Shkreli
Health
Turing Says it Will Lower Daraprim Price by the End of the Year
By Laura LorenzettiNovember 4, 2015
Fortune Global Forum 2015
Health
How the U.S. Subsidizes Europe’s Health Care Costs
By Beth KowittNovember 3, 2015
Hedge fund manager Bill Ackman
Finance
Bill Ackman on Valeant: ‘Life will go on’
By Stephen GandelOctober 30, 2015
1...
  • 86
  • 87
  • 88
  • 89
  • 90
...100
Most Popular
Success
Mark Cuban says he has the solution to growing income inequality, and it's to reward every employee—from CEO to janitor—with company stockplaceholder alt text
By Sasha RogelbergJuly 20, 2026
Success
‘I want to die broke’: Billionaire philanthropist Denny Sanford dies after giving away $4 billionplaceholder alt text
By Sydney LakeJuly 20, 2026
Cybersecurity
OpenAI says its AI models secretly broke out of a secure test environment and hacked into AI company Hugging Face in order to cheat on an evaluationplaceholder alt text
By Jeremy Kahn and Emily ForliniJuly 21, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.